Dr. Kristen Kells discusses the pros and cons of GLP-1 drugs and why the Dr. Kells Method works so well for lasting results.

The MHRA reveals a staggering rise in deaths linked to weight loss and diabetes medications in the UK, with concerns over ...

The FDA recently removed semaglutide from its drug shortage list, which has not been considered commercially available since ...

“The thing most amazing about them is how these drugs suddenly alter the dopamine-related reward pathway in the brain making us less of a slave to cravings. Today, 73% of Americans are obese or ...

Popular weight loss GLP-1 injections are becoming a helpful tool to cardiologists treating heart disease. CBS' Bradley ...

Given the complexity of women’s hormones, it’s hard to know the cause of bloating. Maybe it’s that greasy burger or maybe it’s because our menstrual cycle is approaching, but either way, bloating is a ...

Older people naturally lose muscle as they age, especially with rapid weight loss, which can cause people to become frail and ...

When Trova Wine and Market in Dallas shut its doors last month after nearly five years in business, owner Michelle Bonds ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarterit ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...

Madrigal Pharmaceuticals, Inc.'s Rezdiffra, the first approved drug for MASH, showed strong sales growth, with Q4 net sales ...